Molecular Pharmacology Stock Performance

Molecular Pharmacology Relative Risk vs. Return Landscape

If you would invest  0.04  in Molecular Pharmacology on November 17, 2025 and sell it today you would lose (0.01) from holding Molecular Pharmacology or give up 25.0% of portfolio value over 90 days. Molecular Pharmacology is currently generating 22.0796% in daily expected returns and assumes 144.0805% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Molecular, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.Given the investment horizon of 90 days Molecular Pharmacology is expected to generate 188.59 times more return on investment than the market. However, the company is 188.59 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Molecular Pharmacology Target Price Odds to finish over Current Price

Given the investment horizon of 90 days the pink sheet has the beta coefficient of 77.48 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Molecular Pharmacology will likely underperform. In addition to that Molecular Pharmacology has an alpha of 29.484, implying that it can generate a 29.48 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).

Predictive Modules for Molecular Pharmacology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Molecular Pharmacology. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.0003 50.02 Details

Intrinsic Valuation Low Real High 0.00 0 50.02 Details

Molecular Pharmacology Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Molecular Pharmacology is not an exception. The market had few large corrections towards the Molecular Pharmacology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Molecular Pharmacology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Molecular Pharmacology within the framework of very fundamental risk indicators.

Molecular Pharmacology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Molecular Pharmacology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Molecular Pharmacology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.

Molecular Pharmacology Fundamentals Growth

When running Molecular Pharmacology's price analysis, check to measure Molecular Pharmacology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Pharmacology is operating at the current time. Most of Molecular Pharmacology's value examination focuses on studying past and present price action to predict the probability of Molecular Pharmacology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Pharmacology's price. Additionally, you may evaluate how the addition of Molecular Pharmacology to your portfolios can decrease your overall portfolio volatility.